Nandrolone Phenylpropionate Powder is a steroidal raw material also known as NPP, Nandrolone Phenpropionate, Nandrolone Hydrocinnamate, and historically marketed under the brand name Durabolin. AAS Raw Pharma supplies white or almost white crystalline Nandrolone Phenylpropionate raw powder with a stated purity of 99.4% for qualified laboratory research, analytical reference work, method development, and legally authorised pharmaceutical manufacturing.
The compound is identified by CAS 62-90-8, molecular formula C27H34O3, and molecular weight 406.56 g/mol. Independent reference sources — including PubChem, the FDA substance record, the NIST Chemistry WebBook, and established analytical-reference suppliers — report consistent identity data for this substance.
AAS Raw Pharma supports qualified sample, development, and bulk enquiries subject to product availability, customer verification, destination regulations, and a documented lawful end use. Customers may request current batch specifications, available quality documentation, packaging options, and a commercial quotation before ordering.
Important notice: This listing is for a bulk chemical raw material. It is not a finished medicine, sterile injectable preparation, dietary supplement, or consumer product, and it is not intended for direct human or veterinary administration. Nandrolone Phenylpropionate is classified as a controlled substance in many jurisdictions. Buyers are responsible for confirming that purchase, possession, importation, handling, storage, processing, and intended use are lawful. Nandrolone Phenylpropionate Powder
Nandrolone Phenylpropionate Powder is the phenylpropionate ester of nandrolone. The ester group distinguishes it from Nandrolone Decanoate, Nandrolone Laurate, Nandrolone Propionate, and unesterified nandrolone base. Each of these is a separate chemical substance with its own CAS number, molecular formula, and molecular weight.
The compound is widely recognised under the names NPP and Durabolin. It is commonly described as one of the more widely used nandrolone esters alongside nandrolone decanoate, and it has appeared in pharmaceutical markets in several countries including the United Kingdom and Canada.
AAS Raw Pharma supplies the material strictly as a bulk raw active ingredient for qualified professional customers. The powder has not been formulated, sterilised, or released as a finished pharmaceutical product.
| Specification | Product details |
|---|---|
| Product name | Nandrolone Phenylpropionate Powder |
| Alternative name | Nandrolone Phenpropionate |
| Additional synonym | Nandrolone Hydrocinnamate |
| Common market names | NPP, Durabolin |
| Chemical description | 3-oxoestr-4-en-17-beta-yl 3-phenylpropionate |
| CAS number | 62-90-8 |
| UNII | KF7Z9K2T3W |
| EINECS number | 200-551-9 |
| Molecular formula | C27H34O3 |
| Molecular weight | 406.56 g/mol |
| Stated purity | 99.4%, subject to batch documentation |
| Appearance | White or almost white crystalline powder |
| Physical form | Crystalline solid |
| Listed grade | Pharmaceutical raw-material grade |
| Listed reference standard | USP, where documentation confirms it |
| Packaging | Sealed foil bag, tin, or approved bulk packaging |
| Documentation | Batch-specific COA and technical documents where available |
| Intended users | Qualified laboratories, institutions, and authorised manufacturers |
| Direct administration | Not permitted; this is not a finished product |
The CAS number, formula, and molecular weight are independently supported. PubChem records CID 229455 with formula C27H34O3 and molecular weight 406.6 g/mol. The FDA’s validated substance record lists Nandrolone Phenpropionate under UNII KF7Z9K2T3W with CAS 62-90-8. NIST reports a molecular weight of 406.5571.
Final product acceptance should rest on the batch label, agreed specification, available Certificate of Analysis, and the customer’s own quality procedures.
The substance is identified by:
LGC’s reference listing records the accurate mass as 406.2508 and gives the systematic IUPAC description for the phenylpropanoate ester. Chemical databases also record EINECS 200-551-9 for this substance.
These identifiers should appear consistently in quotations, purchase orders, quality records, package labels, and receiving documentation. Using the full chemical name and CAS number reduces the risk of confusion with other nandrolone esters.
The material may appear under several names in catalogues, databases, and commercial enquiries:
NIST’s record lists Durabolin, Fenobolin, Nandrolin, Nerobil, and Nortestosterone Phenylpropionate among the recognised synonyms. PubChem additionally records Nortestosterone Phenylpropionate and Nandrolon Phenylpropionate.
For procurement accuracy, the clearest description is Nandrolone Phenylpropionate Powder, CAS 62-90-8.
AAS Raw Pharma describes the product as white or almost white crystalline powder. The WHO’s International Programme on Chemical Safety describes Nandrolone Phenylpropionate as white to creamy-white solid crystals with a slight characteristic odour, practically insoluble in water and soluble in alcohol.
Current raw-material catalogues commonly describe a white to off-white crystalline powder. Cayman Chemical describes its reference material as a crystalline solid.
Colour can vary slightly between batches and does not confirm identity, assay, or purity. Visual inspection should be one part of an incoming-material procedure that includes documentation verification and appropriate analytical testing.
The stated purity for this product is 99.4%, subject to confirmation in the documentation for the supplied batch. Purity should be read together with the method used, the batch tested, the acceptance criteria, and the resulting report.
For context on how differently reference products are specified, Cayman Chemical lists a purity of at least 98% for its analytical reference standard, and one published COA from that supplier records an HPLC purity result of 99.6% against a specification of at least 98%, alongside infrared, mass spectrometry, TLC, UV, and NMR results. LGC’s TRC listing states greater than 95% by HPLC.
Those values describe entirely different products and testing programmes. They cannot be used to substantiate or contradict the AAS Raw Pharma batch, which must be documented on its own COA.
A Certificate of Analysis, or COA, is a batch-specific quality document summarising the tests performed and results obtained for a defined lot. Depending on the AAS Raw Pharma specification, a COA may include:
An analytical reference COA demonstrates the value of reporting individual identity tests rather than only a headline purity figure. Its example includes infrared identification, mass spectrometry, NMR, TLC purity, UV maximum, and HPLC purity. Those results apply to that supplier’s specific lot and must not be presented as results for AAS Raw Pharma material.
Customers should verify that the lot number on any AAS Raw Pharma COA matches the number on the product packaging, and should retain the documents with their incoming-material and release records.
Quality evaluation of a steroidal raw material can extend well beyond a single purity figure. Depending on the agreed specification and lawful intended application, assessment may cover:
Some current supplier pages describe batch testing for identity, assay, impurities, and ester content, together with third-party purity, heavy-metals, endotoxin, and sterility reports. Those programmes belong to other suppliers’ products and cannot be applied to the AAS Raw Pharma batch.
AAS Raw Pharma should claim only tests that were actually performed and documented for the supplied batch. Avoid describing the product as HPLC tested, GC-MS verified, NMR confirmed, heavy-metal tested, residual-solvent tested, sterile, endotoxin-free, or pharmacopoeia compliant unless those results appear in the batch records.
Customers operating under formal quality systems should apply their own sampling, quarantine, testing, review, and release procedures.
The supplied draft lists a reference standard of USP30. A reference-standard statement should be supported by documentation that identifies the applicable edition, the specification tested, and the batch results.
A USP reference standard is a highly characterised material used for analytical comparison; it is not the same thing as a commercial raw material that happens to be tested against a USP method. Several supplier pages use terms such as “USP grade,” “GMP,” or “API” loosely, and those claims should not be repeated without current, verifiable evidence.
Similarly, describing a material as pharmaceutical grade does not by itself establish that the powder is:
If the product is manufactured against an internal or enterprise specification, describe it that way. Precise wording is more credible — and safer — than a broad quality claim.
The supplied product information includes a refrigeration note stating that at room temperature above approximately 20 degrees C the material may agglomerate, and at around 30 degrees C may become liquid. That behaviour should be described accurately and supported by batch-specific stability information if it is to be published.
Reference suppliers specify different storage conditions for different formats. Cayman Chemical lists -20 degrees C for its reference standard, LGC’s Dr. Ehrenstorfer listing states +4 degrees C, and the WHO monograph recommends storing the substance in airtight containers protected from light, with parenteral vials stored at room temperature between 15 and 30 degrees C.
Those conditions apply to those specific products. The correct condition for the AAS Raw Pharma raw powder must come from its own label, specification, or stability data.
General storage practice:
Do not publish a specific shelf life or temperature range without supporting documentation.
A crystalline raw material is fundamentally different from a sterile finished medicine. Manufacturing a regulated injectable requires controls that may include approved formulation development, qualified starting materials, validated facilities and processes, sterility assurance, endotoxin control, particulate testing, container-closure qualification, stability studies, finished-product release testing, and regulatory authorisation.
Reference suppliers describe Nandrolone Phenylpropionate Powder as intended for research and forensic applications and explicitly state that it is not for human or veterinary use. That positioning is appropriate for a bulk raw material listing.
A stated purity of 99.4% does not demonstrate sterility, freedom from endotoxins, injectable suitability, clinical safety, or regulatory approval. AAS Raw Pharma does not provide compounding, conversion, filtration, injection, or administration instructions.
Nandrolone Phenylpropionate Powder should be treated as a hazardous substance in a professional setting. PubChem’s hazard classification records include carcinogenicity and reproductive-toxicity endpoints, and the substance should be handled only by trained personnel under a documented risk assessment.
Appropriate controls may include:
The powder must not be tasted, swallowed, inhaled, injected, or applied to the body, and must never be administered to a person or animal. It must be kept away from children and unauthorised persons. Personnel should review the applicable Safety Data Sheet before opening or handling the material.
Nandrolone Phenylpropionate Powder is a controlled substance in a number of jurisdictions. Cayman Chemical identifies its reference material as a Schedule III restricted product in the United States and limits it to research and forensic applications. The FDA substance record carries a corresponding controlled-substance designation for nandrolone phenpropionate.
Classification elsewhere differs. Depending on destination and intended use, a purchaser may require:
The buyer should obtain independent legal and regulatory advice where necessary. Publishing this product page does not establish that the substance may be acquired, imported, or used in any particular location.
Several passages in the supplied draft describe personal use, performance outcomes, and shipping practices that are inappropriate for a raw-material product page. These should be removed or replaced:
| Remove or rewrite | Reason |
|---|---|
| “Great for users who enjoy short, quick blasts or cycles” | Cycle guidance for a bulk raw ingredient |
| “More frequent pinning schedule” | Injection guidance |
| “Joint relief benefits,” “deca bloat,” “moon face” | Personal-use outcome claims |
| “Each millilitre will yield a higher dose of active compound” | Dosage framing for raw material |
| “Users can see results sooner,” “shorter cycles,” “begin recovery faster” | Performance and cycle claims |
| “One of the most popular injectable steroids” | Promotes a finished-product use, not a raw material |
| “Well disguised packing,” “100% custom rate,” “quality guarantee 100%” | Unsupportable shipping and quality assurances |
| “Why Choose Boldenone Cypionate Raw Powder from AAS Raw Pharma?” | Wrong product name in the heading |
Removing these passages protects the page from unsubstantiated-claim risk and keeps the listing focused on what it actually is: a documented raw chemical material for lawful professional use.
Subject to applicable law and customer qualification, Nandrolone Phenylpropionate raw material may be relevant to:
Reference suppliers position this material for research and forensic applications, and that framing fits a bulk raw material listing. Availability does not authorise any particular use. Each buyer must confirm that its organisation, personnel, facilities, licences, and intended activity comply with the applicable regulatory framework.
Nandrolone Phenylpropionate and Nandrolone Decanoate are related but chemically distinct substances with different ester groups.
| Feature | Nandrolone Phenylpropionate | Nandrolone Decanoate |
|---|---|---|
| Ester group | Phenylpropionate (phenpropionate) | Decanoate |
| CAS number | 62-90-8 | Different identifier |
| Molecular formula | C27H34O3 | Different formula |
| Molecular weight | Approximately 406.56 g/mol | Higher molecular weight |
| Common market name | NPP, Durabolin | Deca-Durabolin |
| Same raw material | No | No |
| Interchangeable | No | No |
Both are nandrolone esters, but they are separate products and must be specified precisely on quotations, purchase orders, and receiving documents. Substituting one for the other without technical and regulatory assessment is not acceptable.
Nandrolone Phenylpropionate Powder is also distinct from unesterified nandrolone.
| Feature | Nandrolone Phenylpropionate | Nandrolone base |
|---|---|---|
| Chemical form | Phenylpropionate ester | Unesterified parent compound |
| CAS number | 62-90-8 | 434-22-0 |
| Molecular formula | C27H34O3 | C18H26O2 |
| Molecular weight | Approximately 406.56 g/mol | Approximately 274.4 g/mol |
Some supplier pages publish the nandrolone base formula and molecular weight against a Nandrolone Phenylpropionate listing, which is an identity error. Buyers should treat conflicting formula or molecular-weight data as a red flag and verify against authoritative references before ordering.
Packaging should protect the powder from moisture, light, contamination, and physical damage while maintaining clear product and batch identification. Options may include:
The supplied draft lists packing at 5 kg per tin; the final packaging configuration should be confirmed against current stock and the quotation. Every package should carry the product name, CAS number, batch reference, quantity, and relevant handling information.
Packaging must satisfy applicable carrier, export, import, and destination requirements. AAS Raw Pharma does not offer disguised, mislabeled, or falsely declared shipments, and shipping documents and customs declarations must accurately identify the goods.
Samples may be available to qualified laboratories, institutions, and authorised buyers, subject to inventory, customer verification, destination law, and intended lawful use. Sample availability and any associated charges should be confirmed in writing.
For a sample or bulk quotation, provide:
Availability, minimum order quantity, pricing, production capacity, and lead time should be confirmed in a formal quotation. Avoid publishing “free samples” or guaranteed capacity unless those terms are current and consistently fulfilled.
AAS Raw Pharma supports qualified customers seeking documented steroidal raw materials for lawful professional applications.
The listed purity is 99.4%, subject to the analytical results documented for the supplied batch.
The product is described using its correct chemical name, CAS number, molecular formula, and molecular weight, drawn from authoritative reference data.
Customers may request the available COA, SDS, specification, and supporting technical information for the current batch before purchase.
Direct commercial sourcing can support competitive quotations for approved development and bulk requirements. Final pricing depends on quantity, testing, packaging, stock, and destination.
Sample, development, and bulk requirements can be assessed according to stock, customer qualification, and applicable regulations.
Packaging is selected to protect the powder and preserve product and batch identification throughout lawful storage and transport.
The sales team can review logistics options for destinations where exportation, transport, importation, possession, and intended use are lawful.
Support is available for specifications, documentation, quotations, packaging, and shipment enquiries. Any discrepancy should be reported promptly with the relevant order and batch details.
Send AAS Raw Pharma complete and accurate purchasing information:
AAS Raw Pharma may request additional information before accepting an order. Submission of an enquiry does not guarantee availability, customs clearance, or approval.
International delivery may be considered where the shipment is lawful and accepted by an appropriate carrier. Possible providers may include DHL, FedEx, UPS, TNT, EMS, or a specialist freight service, depending on route, quantity, classification, and packaging.
The buyer is responsible for confirming import eligibility, customs classification, controlled-substance rules, pharmaceutical or veterinary licensing, carrier acceptance, duties and taxes, storage obligations, and local possession requirements.
Because Nandrolone Phenylpropionate Powder is controlled in many countries, an import may require documentation and licensing that a non-controlled chemical would not. AAS Raw Pharma does not guarantee customs clearance and does not support deceptive labels, false values, or inaccurate declarations.
This page provides technical and commercial information about a raw chemical material. It does not recommend Nandrolone Phenylpropionate for bodybuilding, muscle growth, joint relief, athletic performance, weight management, hormone therapy, or any personal application.
No dosage, cycle, injection, or stacking guidance is included. Such information is inappropriate for a bulk raw ingredient and could facilitate unsafe or unlawful administration.
AAS Raw Pharma does not claim that this raw material diagnoses, treats, cures, or prevents any disease. Any legitimate medical use of a finished medicine must be determined by a licensed healthcare professional and governed by the relevant regulator.
Nandrolone Phenylpropionate Powder is the crystalline raw form of the phenylpropionate (phenpropionate) ester of nandrolone, supplied for qualified research, analytical, and legally authorised professional applications.
Durabolin is a historical brand name associated with Nandrolone Phenylpropionate. The raw powder offered by AAS Raw Pharma is not a finished branded medicine.
NPP is a common abbreviation for Nandrolone Phenylpropionate. Formal purchasing documents should use the full chemical name and CAS number.
The CAS number is 62-90-8.
The molecular formula is C27H34O3.
The molecular weight is approximately 406.56 g/mol.
The AAS Raw Pharma specification describes a white or almost white crystalline powder. Reference sources describe white to creamy-white crystals with a slight characteristic odour.
The stated purity is 99.4%, subject to the batch’s Certificate of Analysis.
Batch documentation may be available on request. Customers should confirm the exact COA, SDS, and specification supplied with their order.
The supplied specification lists a USP reference standard. Customers should request the specific specification and batch documentation that support any pharmacopoeial claim before relying on it.
Sterility must not be assumed. Unless a batch has been produced, tested, and released to a documented sterile specification, treat it as non-sterile raw material.
No. Raw powder is not a sterile injectable preparation and must not be injected or administered.
No. It is not intended for direct ingestion, injection, self-administration, veterinary use, or any personal application.
No. Dosage, cycle, injection, and stacking instructions are inappropriate for a bulk raw chemical.
No. They contain different ester groups and are separate chemical substances with different identifiers. They are not interchangeable.
No. Nandrolone Phenylpropionate and unesterified nandrolone have different CAS numbers, formulas, and molecular weights.
The supplied product information notes that at higher ambient temperatures the material may agglomerate or become liquid. The correct storage condition should be taken from the batch label and supporting documentation rather than from a general statement.
Samples may be available to qualified customers, subject to inventory, intended use, verification, destination law, and commercial terms.
Bulk enquiries can be assessed according to stock, production capacity, documentation, quantity, customer qualification, and destination requirements.
Possible formats include sealed foil bags, tins, protective containers, or approved bulk packaging, depending on quantity and transport needs.
International delivery may be possible where exportation, transport, importation, possession, and intended use are lawful.
No. The buyer is responsible for permits, declarations, duties, taxes, and destination-country requirements.
Provide the quantity, destination, organisation details, intended lawful use, packaging preference, and required documentation. AAS Raw Pharma can then assess the enquiry. Nandrolone Phenylpropionate Powder
